{"id":19184,"date":"2016-02-16T17:59:12","date_gmt":"2016-02-16T14:59:12","guid":{"rendered":"http:\/\/en.ldaily.ua\/?p=19184"},"modified":"2016-02-16T17:59:12","modified_gmt":"2016-02-16T14:59:12","slug":"biopharma-is-going-to-invest-12-million-in-its-development-in-2016","status":"publish","type":"news","link":"https:\/\/ldaily.ua\/en\/news\/novosti\/biopharma-is-going-to-invest-12-million-in-its-development-in-2016\/","title":{"rendered":"Biopharma is going to invest $ 12 million in its development in 2016"},"content":{"rendered":"<p style=\"text-align: justify;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-19185 size-medium\" src=\"https:\/\/ldaily.ua\/wp-content\/uploads\/2016\/02\/Biofarma_zavod-211x200.png\" alt=\"Biopharma is going to invest $ 12 million in its development in 2016\" width=\"211\" height=\"200\" title=\"\" srcset=\"https:\/\/ldaily.ua\/wp-content\/uploads\/2016\/02\/Biofarma_zavod-211x200.png 211w, https:\/\/ldaily.ua\/wp-content\/uploads\/2016\/02\/Biofarma_zavod-284x270.png 284w, https:\/\/ldaily.ua\/wp-content\/uploads\/2016\/02\/Biofarma_zavod.png 500w\" sizes=\"auto, (max-width: 211px) 100vw, 211px\" \/><em>In 2015, the company built a plant for the production of probiotics, conducted a reconstruction of the station for a blood transfusion, as well as invested in the development of new drugs.<\/em><\/p>\n<p style=\"text-align: justify;\">The Pharmaceutical company Biopharma (Kiev region) intends to keep the volume of investments in development at the level of 2015 &#8211; $ 12 million in 2016.<\/p>\n<p style=\"text-align: justify;\">&#8220;In general, in 2015, our investments totaled $ 12 million. We plan to keep the same level for 2016&#8221;, &#8211; said the chairman of the board of directors, Konstantin Efimenko.<\/p>\n<p style=\"text-align: justify;\">He said that last year, Biopharma invested $ 5 million for building a probiotics plant and $ 3 million &#8211; in the reconstruction of the Sumy blood transfusion station. Another $ 2 million were invested in the development of new drugs.<\/p>\n<p style=\"text-align: justify;\">In addition, according to K. Efimenko in 2015 Biopharma renewed marketing and sales service.<\/p>\n<p style=\"text-align: justify;\">&#8220;Now in our guide there are persons with experience in well-known international corporations. It is important today, as we launched a number of new products in 2015 and now we prepare new forms of already known our products, including nasal sprays, eye drops and suppositories. Probiotics are running in active promotion\u201d, &#8211; he said.<\/p>\n<p style=\"text-align: justify;\">At the same time, \u00a0K.Efimenko stressed that blood products are the priority for the company. In terms of money, the sales income is 40%.<\/p>\n<p style=\"text-align: justify;\"><em>Biopharma \u00a0is among the ten largest Ukrainian manufacturers of medical products. It produces more than 20 immunobiological preparations from donated blood and products derived from recombinant DNA technology and probiotics.<\/em><\/p>\n<p style=\"text-align: justify;\">In 2014 Biopharma \u00a0built a pharmaceutical factory in Bila Tserkva (Kiev region). Investments amounted to $ 42 million.<\/p>\n<p style=\"text-align: justify;\">At the end of 2014 Biopharma \u00a0reduced net income by 9.91% in comparison with 2013 year &#8211; up to 25.801 million UAH.<\/p>\n<p style=\"text-align: justify;\">Source: delo.ua<\/p>\n","protected":false},"featured_media":19185,"menu_order":0,"template":"","newscat":[9],"newstag":[],"issues":[],"class_list":["post-19184","news","type-news","status-publish","has-post-thumbnail","hentry","newscat-novosti"],"_links":{"self":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/news\/19184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/media\/19185"}],"wp:attachment":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/media?parent=19184"}],"wp:term":[{"taxonomy":"newscat","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/newscat?post=19184"},{"taxonomy":"newstag","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/newstag?post=19184"},{"taxonomy":"issues","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/issues?post=19184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}